References
- Dodson LF, Hawkins WG, Goedegebuure P. Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy 2011; 3:517 - 37; http://dx.doi.org/10.2217/imt.11.10; PMID: 21463193
- Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, et al. Stromal biology and therapy in pancreatic cancer. Gut 2011; 60:861 - 8; http://dx.doi.org/10.1136/gut.2010.226092; PMID: 20966025
- Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, Friess H. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 2012; 9:454 - 67; http://dx.doi.org/10.1038/nrgastro.2012.115; PMID: 22710569
- Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122:787 - 95; http://dx.doi.org/10.1172/JCI59643; PMID: 22378047
- Benson DD, Meng X, Fullerton DA, Moore EE, Lee JH, Ao L, Silliman CC, Barnett CC Jr.. Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma. Am J Physiol Regul Integr Comp Physiol 2012; 302:R1067 - 75; http://dx.doi.org/10.1152/ajpregu.00320.2011; PMID: 22422663
- Gironella M, Folch-Puy E, LeGoffic A, Garcia S, Christa L, Smith A, Tebar L, Hunt SP, Bayne R, Smith AJ, et al. Experimental acute pancreatitis in PAP/HIP knock-out mice. Gut 2007; 56:1091 - 7; http://dx.doi.org/10.1136/gut.2006.116087; PMID: 17409121
- Gironella M, Calvo C, Fernández A, Closa D, Iovanna JL, Roselló-Catafau J, Folch-Puy E. Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization. Cancer Res 2013; 73:5682 - 94; http://dx.doi.org/10.1158/0008-5472.CAN-12-3057; PMID: 23867474
- Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res 2005; 65:3437 - 46; PMID: 15833879
- Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331:1612 - 6; http://dx.doi.org/10.1126/science.1198443; PMID: 21436454
- Wörmann SM, Diakopoulos KN, Lesina M, Algül H. The immune network in pancreatic cancer development and progression. Oncogene 2013; Forthcoming http://dx.doi.org/10.1038/onc.2013.257; PMID: 23851493